{
    "clinical_study": {
        "@rank": "144756", 
        "arm_group": [
            {
                "arm_group_label": "Bioseal Fibrin Sealant", 
                "arm_group_type": "Experimental", 
                "description": "A porcine-derived fibrin sealant consisting of thrombin and fibrinogen"
            }, 
            {
                "arm_group_label": "Manual compression", 
                "arm_group_type": "Other", 
                "description": "Manual compresssion (MC) include any active or inactive adjunctive treatment to hemostasis methods currently used based on each surgeons surgical practice except for the use of other fibrin sealants."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the clinical utility of Bioseal as an adjunct to control bleeding during\n      elective vascular surgery."
        }, 
        "brief_title": "The Bioseal Vascular Study", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiovascular Bleeding", 
            "Vascular Bleeding", 
            "Hemorrhage"
        ], 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects between 18 and 75 years of age;\n\n          2. Undergoing elective vascular surgical procedures and with the  presence of an\n             appropriate Target Bleeding Site (TBS) requiring an adjunct to achieve hemostasis as\n             identified intra-operatively by the surgeon  ;\n\n          3. Able  and willing to comply with procedures required by protocol;\n\n          4. Signed and dated written informed consent prior to any study related procedures.\n\n        Exclusion Criteria:\n\n          1. Subjects with any intra-operative findings that may preclude conducting of the study\n             procedures;\n\n          2. Intended use of Fibrin Sealants (including autologous Fibrin Sealants) other than\n             Bioseal on the TBS;\n\n          3. Subjects with known intolerance to blood products or to one of the components of the\n             study product or unwilling to receive blood products;\n\n          4. Subjects with known allergies to or previously used porcine derived products;\n\n          5. Female subjects who are known breastfeeding or pregnant or intend to become pregnant\n             during the clinical study period.\n\n          6. The subject, in the opinion of the investigator, would not be suitable for\n             participation in the study.\n\n          7. Subjects who participated in another trial within 30 days prior to the planned start\n             of treatment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02094885", 
            "org_study_id": "BIOS-13-003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bioseal Fibrin Sealant", 
                "intervention_name": "Bioseal Fibrin Sealant", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Manual compression", 
                "intervention_name": "Manual Compression", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fibrin Tissue Adhesive"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou City", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510080"
                    }, 
                    "name": "Clinical Investigation Site #21"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "210008"
                    }, 
                    "name": "Clinical Investigation Site #32"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "210029"
                    }, 
                    "name": "Clinical Investigation Site #31"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250021"
                    }, 
                    "name": "Clinical Investigation Site #30"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "Clinical Investigation Site #22"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100029"
                    }, 
                    "name": "Clinical Investigation Site #26"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100853"
                    }, 
                    "name": "Clinical Investigation Site #28"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "zip": "2000011"
                    }, 
                    "name": "Clinical Investigation Site #25"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "zip": "200032"
                    }, 
                    "name": "Clinical Investigation Site #23"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Manual Compression as an Adjunct to Hemostasis in the Patients Undergoing Elective Vascular Surgery", 
        "overall_contact": {
            "email": "jbatill2@its.jnj.com", 
            "last_name": "Jonathan Batiller, MBA", 
            "phone": "908-218-2492"
        }, 
        "overall_contact_backup": {
            "email": "XSun5@its.jnj.com", 
            "last_name": "Xiaowei Sun, MD, PhD", 
            "phone": "+86 10 5952 3103"
        }, 
        "overall_official": {
            "affiliation": "Ethicon, Inc.", 
            "last_name": "Richard Kocharian, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hemostasis at the TBS at 10 minutes following the completion of treatment application.  Hemostasis is defined as no detectable bleeding at the TBS.", 
            "safety_issue": "Yes", 
            "time_frame": "Intra-operative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02094885"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Hemostasis at the TBS at 3 and 6 minutes following  the completion of treatment application", 
                "safety_issue": "Yes", 
                "time_frame": "Intra-operative"
            }, 
            {
                "measure": "Incidence of treatment failures.", 
                "safety_issue": "Yes", 
                "time_frame": "Intra-operative"
            }, 
            {
                "measure": "Incidence of potential bleeding-related adverse events.", 
                "safety_issue": "Yes", 
                "time_frame": "30-days follow-up"
            }
        ], 
        "source": "Ethicon, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Guangzhou Bioseal Biotechnology Co., Ltd.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ethicon, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}